低肾素性高血压（LRH）：约翰·拉拉格的观点 - Suppr

Suppr

超能文献

Low renin hypertension (LRH): shades of John Laragh.

作者信息

Funder John, New Maria I

出版信息

Trends Endocrinol Metab. 2008 Apr;19(3):83. doi: 10.1016/j.tem.2008.01.008. Epub 2008 Mar 18.

DOI:10.1016/j.tem.2008.01.008

PMID:18353670

Abstract

摘要

相似文献

Low renin hypertension (LRH): shades of John Laragh.

Trends Endocrinol Metab. 2008 Apr;19(3):83. doi: 10.1016/j.tem.2008.01.008. Epub 2008 Mar 18.

Primary aldosteronism: the most frequent form of secondary hypertension?

Isr Med Assoc J. 2002 Jan;4(1):32-3.

[Present hypertension problems].

Schweiz Med Wochenschr. 1967 Mar 18;97(11):355-9.

How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?

J Hypertens Suppl. 1993 Dec;11(5):S310-1.

[Is there an unrecognized epidemic of primary aldosteronism? The Danish Society of Hypertension].

Ugeskr Laeger. 2008 Mar 17;170(12):1030.

[Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].

Rev Med Chil. 1999 May;127(5):604-10.

Evaluation of patients for secondary hypertension.

Compr Ther. 1977 May;3(5):8-11.

[How to unravel hyperaldosteronism in clinical practice].

MMW Fortschr Med. 2014 Oct 9;156(17):61-2.

Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.

Trends Endocrinol Metab. 2008 Apr;19(3):104-8. doi: 10.1016/j.tem.2008.01.005. Epub 2008 Mar 4.

The spectrum of low-renin hypertension.

Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101399. doi: 10.1016/j.beem.2020.101399. Epub 2020 Feb 25.

引用本文的文献

DOCA-Salt Hypertension: an Update.

Curr Hypertens Rep. 2017 Apr;19(4):32. doi: 10.1007/s11906-017-0731-4.

Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.

Antioxid Redox Signal. 2014 Nov 20;21(15):2126-42. doi: 10.1089/ars.2013.5565. Epub 2014 Mar 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Low renin hypertension (LRH): shades of John Laragh.

Trends Endocrinol Metab. 2008 Apr;19(3):83. doi: 10.1016/j.tem.2008.01.008. Epub 2008 Mar 18.

Primary aldosteronism: the most frequent form of secondary hypertension?

Isr Med Assoc J. 2002 Jan;4(1):32-3.

[Present hypertension problems].

Schweiz Med Wochenschr. 1967 Mar 18;97(11):355-9.

How common is primary aldosteronism? Is it the most frequent cause of curable hypertension?

J Hypertens Suppl. 1993 Dec;11(5):S310-1.

[Is there an unrecognized epidemic of primary aldosteronism? The Danish Society of Hypertension].

Ugeskr Laeger. 2008 Mar 17;170(12):1030.

[Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].

Rev Med Chil. 1999 May;127(5):604-10.

Evaluation of patients for secondary hypertension.

Compr Ther. 1977 May;3(5):8-11.

[How to unravel hyperaldosteronism in clinical practice].

MMW Fortschr Med. 2014 Oct 9;156(17):61-2.

Primary aldosteronism, a major form of low renin hypertension: from screening to diagnosis.

Trends Endocrinol Metab. 2008 Apr;19(3):104-8. doi: 10.1016/j.tem.2008.01.005. Epub 2008 Mar 4.

The spectrum of low-renin hypertension.

Best Pract Res Clin Endocrinol Metab. 2020 May;34(3):101399. doi: 10.1016/j.beem.2020.101399. Epub 2020 Feb 25.

引用本文的文献

DOCA-Salt Hypertension: an Update.

Curr Hypertens Rep. 2017 Apr;19(4):32. doi: 10.1007/s11906-017-0731-4.

Aldosterone activates transcription factor Nrf2 in kidney cells both in vitro and in vivo.

Antioxid Redox Signal. 2014 Nov 20;21(15):2126-42. doi: 10.1089/ars.2013.5565. Epub 2014 Mar 21.